title: Commentary: non-haemodynamic effects of beta-blockers in cirrhosis - more than meets the eye? Authors' reply.
authors: Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and McGuire VA Medical Center, Richmond, VA, USA. jsbajaj@vcu.edu
authors: J S
authors: JS
authors: Bajaj
authors: S
authors: S
authors: Ratliff
authors: K
authors: K
authors: Lapane
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology* / Q000627:therapeutic use*; D002352:Carrier Proteins / Q000097:blood*; D002463:Cell Membrane Permeability / Q000187:drug effects*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D007408:Intestinal Absorption / Q000187:drug effects*; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000378:metabolism*; D008297:Male; D008562:Membrane Glycoproteins / Q000097:blood*
chemical_list: D000319:Adrenergic beta-Antagonists; D002352:Carrier Proteins; D015850:Interleukin-6; D008562:Membrane Glycoproteins